Lenskart Solutions Grants 3,47,000 Employee Stock Options at INR 389 Per Share Under ESOP Plan 2021
Lenskart Solutions Limited has granted 3,47,000 Employee Stock Options to eligible employees under its ESOP Plan 2021, following approval by the Nomination and Remuneration Committee on May 8, 2026. Each option is exercisable at INR 389 per share and converts into one equity share with a face value of INR 2 each. The grant is compliant with SEBI (Share Based Employee Benefits) Regulations, 2021, and was disclosed pursuant to Regulation 30 of the SEBI Listing Regulations on May 9, 2026.

*this image is generated using AI for illustrative purposes only.
Lenskart Solutions Limited has announced the grant of 3,47,000 Employee Stock Options (ESOPs) to eligible employees under the Lenskart Employee Stock Option Plan, 2021. The grant was approved by the Nomination and Remuneration Committee of the company through a circular resolution passed on May 8, 2026, and was disclosed to the stock exchanges on May 9, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
ESOP Grant Details
The grant covers eligible employees of the company as well as those of its Group Company, Subsidiary Company(ies), and Associate Company(ies), whether based in India or outside India. The scheme is compliant with the SEBI (Share Based Employee Benefits) Regulations, 2021. The key parameters of the grant are outlined below:
| Parameter: | Details |
|---|---|
| Number of Options Granted: | 3,47,000 Employee Stock Options |
| Plan Name: | Lenskart Employee Stock Option Plan, 2021 |
| Exercise Price: | INR 389 per share |
| Face Value per Share: | INR 2 each |
| Total Equity Shares Covered: | 3,47,000 equity shares |
| Conversion Ratio: | 1 option = 1 equity share |
| Grant Approval Date: | May 8, 2026 |
| Disclosure Date: | May 9, 2026 |
Pricing Formula and Exercise Window
The exercise price of INR 389 per share has been determined based on the average closing price for 30 days prior to the grant date on the stock exchange recording the highest trading volume during that period, subject to a maximum discount of 25% on such price. Options can be exercised, either wholly or partly, at any time during the exercise window while the employee remains in employment with the company, after the applicable vesting period.
Regulatory Compliance
The intimation has been made in accordance with Regulation 30 read with Schedule III of the SEBI Listing Regulations, and in line with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The disclosure was signed by Ashish Srivastava, Company Secretary and Chief Compliance Officer (Membership No.: F5325), from the company's corporate office in Gurugram, Haryana. As the announcement pertains solely to the grant of options, items such as options vested, options exercised, money realized, options lapsed, and diluted earnings per share are reported as not applicable at this stage.
Historical Stock Returns for Lenskart Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.31% | -5.17% | -2.28% | +21.37% | +21.37% | +21.37% |
How might the vesting schedule and exercise timeline for these 3,47,000 ESOPs impact Lenskart's share dilution and earnings per share over the next 3-5 years?
Given that the exercise price of INR 389 is set at up to 25% discount to market price, what does this signal about Lenskart's employee retention strategy amid increasing competition in the eyewear market?
How could the broad eligibility of this ESOP grant — covering employees across subsidiaries and international associates — affect Lenskart's talent acquisition efforts in global markets?


































